Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series

Published:2024-03-05 Issue: Volume: Page:1-4
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Dutta Majumder Parthopratim¹,Abraham Sharanya¹,Sudharshan Sridharan¹,Janarthanan Mahesh²,Ramanan Athimalaipet V³

Affiliation:

1. Department of Uvea & Intraocular inflammation, Sankara Nethralaya, Chennai, India

2. Department of Clinical Immunology & Rheumatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India

3. Bristol Royal Hospital for Children & Translational Health Sciences, University of Bristol, Bristol, UK

Funder

no funding associated

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2024.2323671

Reference15 articles.

1. Pediatric uveitis: An update

2. Pediatric uveitis: A comprehensive review

3. Janus Kinase Antagonists and Other Novel Small Molecules for the Treatment of Crohn's Disease

4. Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward

5. Tofacitinib for refractory uveitis and scleritis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries;Frontiers in Medicine;2024-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP